Moderna (MRNA)

Income Before Tax

-$767.00M

Quarterly · Period ending: · USD

MRNA logo

MRNA Income Before Tax

Latest reported-$767.00M
MRNA Quarterly Pre-Tax Income (-$76.55M → -$767.00M)
High-resolution chart · PNG

MRNA income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-767,000,000
-1,334,000,000
-799,000,000
-187,000,000
-818,000,000
-964,000,000
-1,184,000,000
21,000,000
-1,279,000,000
-1,165,000,000
70,000,000
-1,958,000,000
-1,749,000,000
-305,000,000
1,655,000,000
1,217,000,000
2,474,000,000
4,229,000,000
5,410,000,000
3,552,000,000
3,063,000,000
1,260,000,000
-271,012,000
-232,772,000
-116,565,000
-124,164,000
-123,459,000
-123,393,000
-135,264,000
-132,600,000
-141,258,000
-80,331,000
-90,443,000
-72,376,000
-38,115,000
-64,785,000
-76,548,000
-76,548,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.